{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:17:20Z","timestamp":1790619440947,"version":"4.1.0"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejpb.2024.114597","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T08:03:39Z","timestamp":1733472219000},"page":"114597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Nanomedicine for pediatric healthcare: A review of the current state and future prospectives"],"prefix":"10.1016","volume":"207","author":[{"given":"Jiayi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Alantary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114597_b0005","unstructured":"Federal Food, Drug, and Cosmetic Act (FD&C Act): U.S. Food & Drug Administration; [Available from: https:\/\/www.fda.gov\/regulatory-information\/laws-enforced-fda\/federal-food-drug-and-cosmetic-act-fdc-act."},{"key":"10.1016\/j.ejpb.2024.114597_b0010","unstructured":"L. Fleisher, editor. Anesthesia and Uncommon Diseases: Elsevier Inc., 2012."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrclinonc.2011.95","article-title":"Challenging issues in pediatric oncology","volume":"8","author":"Pui","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114597_b0020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nbt1006-1211","article-title":"The emerging nanomedicine landscape","volume":"24","author":"Wagner","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0025","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat. Rev. Can."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2217\/nnm.09.91","article-title":"Regulation of nanomedicines in the EU: distilling lessons from the pediatric and the advanced therapy medicinal products approaches","volume":"5","author":"Chowdhury","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","article-title":"The big picture on nanomedicine: the state of investigational and approved nanomedicine products","volume":"9","author":"Etheridge","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114597_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmaceutics15030774","article-title":"Approved nanomedicine against diseases","volume":"15","author":"Jia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114597_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.curtheres.2018.12.001","article-title":"Pediatric drug development: challenges and opportunities","volume":"90","author":"Spadoni","year":"2019","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bcp.12268","article-title":"Formulations for children: problems and solutions","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0065","first-page":"262","article-title":"Developmental pharmacokinetics in pediatric populations","volume":"19","author":"Lu","year":"2014","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2024.114597_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105280","article-title":"Impact of gastrointestinal physiology on drug absorption in special populations \u2013 an UNGAP review","volume":"147","author":"Stillhart","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b0075","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/cpt.1332","article-title":"Renal clearance in newborns and infants: predictive performance of population-based modeling for drug development","volume":"105","author":"Wang","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2024.114597_b0080","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212608","article-title":"Neonatal pharmacology and clinical implications","volume":"8","author":"Ruggiero","year":"2019","journal-title":"Drugs Context."},{"issue":"19","key":"10.1016\/j.ejpb.2024.114597_b0085","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ajhp\/zxz161","article-title":"Pharmacokinetic considerations in pediatric pharmacotherapy","volume":"76","author":"Lim","year":"2019","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0090","article-title":"Age transformations of the kidneys structure and function","volume":"2","author":"Aizman","year":"2019","journal-title":"Health Education and Public Health"},{"issue":"8\u20139","key":"10.1016\/j.ejpb.2024.114597_b0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10719-004-5539-1","article-title":"Nano-biosensor development for bacterial detection during human kidney infection: use of glycoconjugate-specific antibody-bound gold NanoWire arrays (GNWA)","volume":"21","author":"Basu","year":"2004","journal-title":"Glycoconj. J."},{"issue":"21","key":"10.1016\/j.ejpb.2024.114597_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ma13214792","article-title":"Third-generation cephalosporin-loaded chitosan used to limit microorganisms resistance","volume":"13","author":"Duceac","year":"2020","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ejpb.2024.114597_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113189","article-title":"Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: Pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes","volume":"151","author":"Dlozi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0110","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/0929867325666180904123549","article-title":"An overview of antiretroviral agents for treating HIV infection in paediatric population","volume":"27","author":"Melo","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2024.114597_b0115","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.2147\/IJN.S108253","article-title":"Decreased Pseudomonas aeruginosa biofilm formation on nanomodified endotracheal tubes: a dynamic lung model","volume":"11","author":"Machado","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114597_b0120","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00431-015-2501-0","article-title":"Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening","volume":"174","author":"Vernooij-van Langen","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ejpb.2024.114597_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103628","article-title":"Nanotechnology for the treatment of paediatric diseases: a review","volume":"75","author":"Marques","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114597_b0130","unstructured":"team TACSmaec. Key Statistics for Childhood Cancers: American Cancer Society; 2024 [updated May 28, 2024. Available from: https:\/\/www.cancer.org\/cancer\/types\/cancer-in-children\/key-statistics.html."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Can. J. Clin."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114597_b0140","article-title":"Hyperleukocytosis in childhood acute leukemia: early complications and survival outcomes","volume":"15","author":"Kittivisuit","year":"2023","journal-title":"Can. (Basel)"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ncl.2018.04.009","article-title":"Pediatric brain tumors","volume":"36","author":"Udaka","year":"2018","journal-title":"Neurol. Clin."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041067","article-title":"Dual targeting of PI3K and HDAC by CUDC-907 inhibits pediatric neuroblastoma growth","volume":"14","author":"Chilamakuri","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114597_b0155","first-page":"1356","article-title":"Genomics of adult and pediatric solid tumors","volume":"8","author":"Rahal","year":"2018","journal-title":"Am. J. Can. Res."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071437","article-title":"Recent developments in nanomedicine for pediatric cancer","volume":"10","author":"Yang","year":"2021","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0165","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2741\/4538","article-title":"Childhood cancers and systems medicine","volume":"22","author":"Stone","year":"2017","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ph11040132","article-title":"Evaluation of radiolabeled girentuximab in vitro and in vivo","volume":"11","author":"Basaco","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejpb.2024.114597_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112140","article-title":"Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation","volume":"143","author":"Saber","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2024.114597_b0180","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2147\/IJN.S290466","article-title":"Preparation, characterization, pharmacokinetic, and therapeutic potential of novel 6-mercaptopurine-loaded oral nanomedicines for acute lymphoblastic leukemia","volume":"16","author":"Zou","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2024.114597_b0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ebiom.2014.10.013","article-title":"A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies","volume":"1","author":"Uckun","year":"2014","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jmoldx.2019.08.008","article-title":"Multiplexed digital detection of B-cell acute lymphoblastic leukemia fusion transcripts using the nanostring nCounter system","volume":"22","author":"Zhong","year":"2020","journal-title":"J. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b0195","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/mp300350e","article-title":"Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine","volume":"10","author":"Krishnan","year":"2013","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114597_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101681","article-title":"Development of siRNA-loaded lipid nanoparticles targeting long non-coding RNA LINC01257 as a novel and safe therapeutic approach for t(8;21) pediatric acute myeloid leukemia","volume":"13","author":"Connerty","year":"2021","journal-title":"Pharmaceutics."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b0205","article-title":"Different microfluidic environments for in vitro testing of lipid nanoparticles against osteosarcoma","volume":"8","author":"Mitxelena-Iribarren","year":"2021","journal-title":"Bioengineering (Basel)"},{"issue":"28","key":"10.1016\/j.ejpb.2024.114597_b0210","doi-asserted-by":"crossref","first-page":"46177","DOI":"10.18632\/oncotarget.17579","article-title":"Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread","volume":"8","author":"Spreafico","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b0215","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.molonc.2015.01.006","article-title":"Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to gamma-irradiation","volume":"9","author":"Kievit","year":"2015","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1093526618790747","article-title":"Sarcoma subgrouping by detection of fusion transcripts using nanostring nCounter technology","volume":"22","author":"Sheth","year":"2019","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.ejpb.2024.114597_b0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2022.12.010","article-title":"Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine","volume":"354","author":"Regenold","year":"2023","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12951-020-00654-x","article-title":"Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells","volume":"18","author":"Haddad","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13046-021-01993-9","article-title":"Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy","volume":"40","author":"Brignole","year":"2021","journal-title":"J. Exp. Clin. Can. Res."},{"key":"10.1016\/j.ejpb.2024.114597_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121058","article-title":"Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma","volume":"608","author":"Burgos-Panadero","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114597_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119345","article-title":"Squalenoyl-gemcitabine\/edelfosine nanoassemblies: anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice","volume":"582","author":"Rodriguez-Nogales","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040780","article-title":"Aptamer-equipped protamine nanomedicine for precision lymphoma therapy","volume":"12","author":"Zeng","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0255","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1080\/10717544.2022.2141921","article-title":"Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114597_b0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canlet.2018.05.030","article-title":"Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma","volume":"430","author":"Gonzalez-Fernandez","year":"2018","journal-title":"Can. Lett."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0265","article-title":"Self-stabilized hyaluronate nanogel for intracellular codelivery of doxorubicin and cisplatin to osteosarcoma","volume":"5","author":"Zhang","year":"2018","journal-title":"Adv. Sci. (Weinh)."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12951-021-00831-6","article-title":"Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma","volume":"19","author":"Zeng","year":"2021","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.ejpb.2024.114597_b0275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jconrel.2022.08.048","article-title":"IL-11Ralpha-targeted nanostrategy empowers chemotherapy of relapsed and patient-derived osteosarcoma","volume":"350","author":"Jiang","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/JEnvironPatholToxicolOncol.v30.i1.10","article-title":"Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo","volume":"30","author":"Maurya","year":"2011","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114597_b0285","doi-asserted-by":"crossref","first-page":"e2489","DOI":"10.1038\/cddis.2016.375","article-title":"1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis","volume":"7","author":"Wei","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1166\/jbn.2017.2331","article-title":"Anti-hMC2RL1 functionalized gold nanoparticles for adrenocortical tumor cells targeting and imaging","volume":"13","author":"Woiski","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2013.12.038","article-title":"Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation","volume":"462","author":"Kotta","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2024.114597_b0300","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2217\/nnm.13.154","article-title":"Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid","volume":"9","author":"Moretton","year":"2014","journal-title":"Nanomedicine (Lond.)"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114597_b0305","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1089\/adt.2018.874","article-title":"Alternative pharmaceutical formulation for oral administration of rifampicin","volume":"16","author":"Halicki","year":"2018","journal-title":"Assay Drug Dev. Technol."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114597_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/v11121111","article-title":"Virucidal activity of gold nanoparticles synthesized by green chemistry using garlic extract","volume":"11","author":"Melendez-Villanueva","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ejpb.2024.114597_b0315","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.phrs.2018.07.005","article-title":"Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives","volume":"134","author":"de Velde","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/dkq449","article-title":"Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients","volume":"66","author":"Roberts","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0325","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3201\/eid0809.020063","article-title":"Biofilms: microbial life on surfaces","volume":"8","author":"Donlan","year":"2002","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0330","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114597_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial antibiotic resistance: the most critical pathogens","volume":"10","author":"Mancuso","year":"2021","journal-title":"Pathogens."},{"key":"10.1016\/j.ejpb.2024.114597_b0340","unstructured":"[Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0345","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2217\/nnm.12.104","article-title":"Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV","volume":"8","author":"Chiappetta","year":"2013","journal-title":"Nanomedicine (Lond.)"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114597_b0350","article-title":"Pediatric tuberculosis management: a global challenge or breakthrough?","volume":"9","author":"Maphalle","year":"2022","journal-title":"Children (Basel)"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0355","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.colsurfb.2010.05.016","article-title":"Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles","volume":"79","author":"Moretton","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2008.11.027","article-title":"One-step preparation of rifampicin\/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis","volume":"135","author":"Ohashi","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114597_b0365","unstructured":"[cited 2024 March 25]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0370","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1208\/s12249-008-9137-6","article-title":"Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate","volume":"9","author":"Shah","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0375","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/10837450903188485","article-title":"Palatable reconstitutable dry suspension of artemether for flexible pediatric dosing using cyclodextrin inclusion complexation","volume":"15","author":"Shah","year":"2010","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2024.114597_b0380","unstructured":"WHO chief declares end to COVID-19 as a global health emergency [Available from: https:\/\/news.un.org\/en\/story\/2023\/05\/1136367."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114597_b0385","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/14737159.2021.1962708","article-title":"Optimizing testing regimes for the detection of COVID-19 in children and older adults","volume":"21","author":"Chauhan","year":"2021","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0390","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41565-021-00939-8","article-title":"Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma","volume":"16","author":"Ning","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b0395","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s43440-022-00425-5","article-title":"Recent review of COVID-19 management: diagnosis, treatment and vaccination","volume":"74","author":"Chavda","year":"2022","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0400","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1203\/PDR.0b013e3181d68e78","article-title":"Nanotechnology: pediatric applications","volume":"67","author":"Machado","year":"2010","journal-title":"Pediatr. Res."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8071023","article-title":"Current practices and potential nanotechnology perspectives for pain related to cystic fibrosis","volume":"8","author":"Trandafir","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0410","article-title":"Applications of silver nanoparticles in pediatric dentistry: an overview","volume":"14","author":"Khubchandani","year":"2022","journal-title":"Cureus."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0415","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00784-013-1026-z","article-title":"The effect of a nano-filled resin coating on the 3-year clinical performance of a conventional high-viscosity glass-ionomer cement","volume":"18","author":"Diem","year":"2014","journal-title":"Clin. Oral Invest."},{"issue":"14","key":"10.1016\/j.ejpb.2024.114597_b0420","doi-asserted-by":"crossref","DOI":"10.3390\/ma14143801","article-title":"An innovative strategy for oral biofilm control in early childhood based on a resveratrol-cyclodextrin nanotechnology approach","volume":"14","author":"Berta","year":"2021","journal-title":"Materials (basel)"},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0425","doi-asserted-by":"crossref","DOI":"10.3390\/ma11091544","article-title":"Tuning nano-amorphous calcium phosphate content in novel rechargeable antibacterial dental sealant","volume":"11","author":"Ibrahim","year":"2018","journal-title":"Materials (basel)"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0430","article-title":"Novel vehicles for drug delivery in atopic dermatitis: A narrative review","volume":"13","author":"Farkouh","year":"2023","journal-title":"Dermatol Pract Concept."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1208\/s12249-021-01920-3","article-title":"Emerging nanomedicines for the treatment of atopic dermatitis","volume":"22","author":"Parekh","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0440","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/03639045.2018.1542704","article-title":"Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting","volume":"45","author":"Md","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0445","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1574891X13666180918114349","article-title":"Nanotechnological carriers for treatment of acne","volume":"13","author":"Verma","year":"2018","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"issue":"13","key":"10.1016\/j.ejpb.2024.114597_b0450","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1039\/C3TB21634A","article-title":"Tailored biological retention and efficient clearance of pegylated ultra-small MnO nanoparticles as positive MRI contrast agents for molecular imaging","volume":"2","author":"Chevallier","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2024.114597_b0455","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/DDDT.S77702","article-title":"Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia","volume":"9","author":"Hosny","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"32","key":"10.1016\/j.ejpb.2024.114597_b0460","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.vaccine.2019.02.079","article-title":"End-user acceptability study of the nanopatch; a microarray patch (MAP) for child immunization in low and middle-income countries","volume":"37","author":"Guillermet","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2024.114597_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","volume":"601","author":"Guimaraes","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0470","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/21691401.2023.2247036","article-title":"Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes","volume":"51","author":"Pande","year":"2023","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0475","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/08982104.2019.1668010","article-title":"A comprehensive review on recent preparation techniques of liposomes","volume":"30","author":"Has","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2024.114597_b0480","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0485","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2024.114597_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.09.018","article-title":"Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release","volume":"315","author":"Abri Aghdam","year":"2019","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0495","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00280-018-3668-7","article-title":"Liposomal therapies in oncology: does one size fit all?","volume":"82","author":"Sousa","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b0500","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acs.molpharmaceut.7b00077","article-title":"Development of a rapidly dissolvable oral pediatric formulation for mefloquine using liposomes","volume":"14","author":"Tang","year":"2017","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0505","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720107782151269","article-title":"Liposomal drug delivery systems: an update review","volume":"4","author":"Samad","year":"2007","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0510","first-page":"7","article-title":"What we need to know about liposomes as drug nanocarriers: an updated review","volume":"13","author":"Abbasi","year":"2023","journal-title":"Adv Pharm Bull."},{"key":"10.1016\/j.ejpb.2024.114597_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.102174","article-title":"Ethanol injection technique for liposomes formulation: An insight into development, influencing factors, challenges and applications","volume":"61","author":"Gouda","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114597_b0520","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4155\/tde-2018-0035","article-title":"Long circulating liposomes: challenges and opportunities","volume":"9","author":"Deodhar","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2024.114597_b0525","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0530","first-page":"202","article-title":"Enzyme replacement via liposomes. Variations in lipid compositions determine liposomal integrity in biological fluids","volume":"587","author":"Finkelstein","year":"1979","journal-title":"BBA"},{"key":"10.1016\/j.ejpb.2024.114597_b0535","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.msec.2014.11.069","article-title":"Development and characterization of oral liposomes of vegetal ceramide based amphotericin B having enhanced dry solubility and solubility","volume":"48","author":"Skiba-Lahiani","year":"2015","journal-title":"Mater Sci Eng C Mater Biol Appl."},{"key":"10.1016\/j.ejpb.2024.114597_b0540","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6750-5-11","article-title":"Liposome retention in size exclusion chromatography","volume":"5","author":"Ruysschaert","year":"2005","journal-title":"BMC Biotech."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0545","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: An updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0550","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050670","article-title":"Polymeric and lipid nanoparticles: which applications in pediatrics?","volume":"13","author":"Nieto Gonzalez","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2024.114597_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122107","article-title":"Development of a child-friendly oral drug formulation using liposomal multilamellar vesicle technology","volume":"625","author":"Al Fayez","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114597_b0560","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5982567","article-title":"EXPAREL(R) (long-acting liposomal bupivacaine) use for popliteal nerve block in postoperative pain control after ankle fracture fixation","volume":"2020","author":"Discepola","year":"2020","journal-title":"Pain Res. Manag."},{"issue":"16","key":"10.1016\/j.ejpb.2024.114597_b0565","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zielinska","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0570","doi-asserted-by":"crossref","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials (basel)"},{"key":"10.1016\/j.ejpb.2024.114597_b0575","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114597_b0580","doi-asserted-by":"crossref","DOI":"10.3390\/nano10101970","article-title":"A review of biodegradable natural polymer-based nanoparticles for drug delivery applications","volume":"10","author":"Idrees","year":"2020","journal-title":"Nanomaterials (Basel)"},{"issue":"17","key":"10.1016\/j.ejpb.2024.114597_b0585","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28176213","article-title":"Advances in biodegradable polymers and biomaterials for medical applications \u2013 a review","volume":"28","author":"Oleksy","year":"2023","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ejpb.2024.114597_b0590","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/mabi.201100324","article-title":"Biodegradable polymers derived from amino acids","volume":"11","author":"Khan","year":"2011","journal-title":"Macromol. Biosci."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0595","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1163\/156856295X00175","article-title":"Biodegradable polymers as biomaterials","volume":"6","author":"Piskin","year":"1995","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ejpb.2024.114597_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.biortech.2021.124739","article-title":"Recent advances in the sustainable design and applications of biodegradable polymers","volume":"325","author":"Rai","year":"2021","journal-title":"Bioresour. Technol."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0605","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041305","article-title":"Design, evaluation and comparison of nanostructured lipid carriers and chitosan nanoparticles as carriers of poorly soluble drugs to develop oral liquid formulations suitable for pediatric use","volume":"15","author":"Nerli","year":"2023","journal-title":"Pharmaceutics."},{"issue":"13","key":"10.1016\/j.ejpb.2024.114597_b0610","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1073\/pnas.1119339109","article-title":"Nanoparticle delivery in infant lungs","volume":"109","author":"Semmler-Behnke","year":"2012","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0615","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12951-022-01343-7","article-title":"The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases","volume":"20","author":"Liu","year":"2022","journal-title":"J Nanobiotechnology."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0620","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.ejpb.2024.114597_b0625","doi-asserted-by":"crossref","DOI":"10.3390\/polym14132601","article-title":"Approaches to improve macromolecule and nanoparticle accumulation in the tumor microenvironment by the enhanced permeability and retention effect","volume":"14","author":"Ejigah","year":"2022","journal-title":"Polymers (basel)"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0630","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0635","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0640","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0645","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1080\/10717544.2020.1837296","article-title":"Radioactive polymeric nanoparticles for biomedical application","volume":"27","author":"Wu","year":"2020","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0650","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43094-022-00400-0","article-title":"Pharmaceutical nanotechnology: from the bench to the market","volume":"8","author":"Mazayen","year":"2022","journal-title":"Futur J Pharm Sci."},{"key":"10.1016\/j.ejpb.2024.114597_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120708","article-title":"Production and isolation of pharmaceutical drug nanoparticles","volume":"603","author":"Verma","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0660","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054333","article-title":"PLGA-based micro\/nanoparticles: an overview of their applications in respiratory diseases","volume":"24","author":"Guo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0665","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"Lu","year":"2009","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.ejpb.2024.114597_b0670","first-page":"99","article-title":"Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer","volume":"4","author":"Miele","year":"2009","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0675","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2024.114597_b0680","first-page":"53","article-title":"Safety and efficacy of nab-paclitaxel in the treatment of patients with breast cancer","volume":"5","author":"Vishnu","year":"2011","journal-title":"Breast Cancer (Auckl.)"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0685","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000573","article-title":"Hydroxyapatite-bovine serum albumin-paclitaxel nanoparticles for locoregional treatment of osteosarcoma","volume":"10","author":"Liu","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2024.114597_b0690","first-page":"5815","article-title":"Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0695","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/jbm.a.34442","article-title":"Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency","volume":"101","author":"Callewaert","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0700","doi-asserted-by":"crossref","DOI":"10.3390\/polym13071027","article-title":"Recent advancements in polymer\/liposome assembly for drug delivery: from surface modifications to hybrid vesicles","volume":"13","author":"De Leo","year":"2021","journal-title":"Polymers (basel)"},{"issue":"23","key":"10.1016\/j.ejpb.2024.114597_b0705","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.2217\/nnm-2017-0221","article-title":"Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapy","volume":"12","author":"Kelly","year":"2017","journal-title":"Nanomedicine (Lond.)"},{"issue":"12","key":"10.1016\/j.ejpb.2024.114597_b0710","doi-asserted-by":"crossref","DOI":"10.3390\/polym14122510","article-title":"A review of polymeric micelles and their applications","volume":"14","author":"Perumal","year":"2022","journal-title":"Polymers (basel)"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0715","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1049\/nbt2.12018","article-title":"Nanomicelles: Types, properties and applications in drug delivery","volume":"15","author":"Bose","year":"2021","journal-title":"IET Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114597_b0720","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081700","article-title":"New advances in biomedical application of polymeric micelles","volume":"14","author":"Figueiras","year":"2022","journal-title":"Pharmaceutics."},{"issue":"23","key":"10.1016\/j.ejpb.2024.114597_b0725","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801221","article-title":"Surfactant free delivery of docetaxel by Poly[(R)-3-hydroxybutyrate-(R)-3-hydroxyhexanoate]-based polymeric micelles for effective melanoma treatments","volume":"7","author":"Luo","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0730","doi-asserted-by":"crossref","DOI":"10.3390\/jfb12040058","article-title":"Polyamide\/poly(amino acid) polymers for drug delivery","volume":"12","author":"Boddu","year":"2021","journal-title":"J Funct Biomater."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0735","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1080\/10717544.2022.2086942","article-title":"Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with astragaloside has anti-osteoporotic effect in rats","volume":"29","author":"Xi","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114597_b0740","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2015.12.015","article-title":"PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery","volume":"240","author":"Cho","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114597_b0745","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.2147\/IJN.S112658","article-title":"PEG-b-PCL polymeric nano-micelle inhibits vascular angiogenesis by activating p53-dependent apoptosis in zebrafish","volume":"11","author":"Zhou","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b0750","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.drudis.2020.04.007","article-title":"HPMA-based polymeric conjugates in anticancer therapeutics","volume":"25","author":"Rani","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2024.114597_b0755","article-title":"Polymeric dexamethasone prodrugs attenuate lupus nephritis in MRL\/lpr mice with reduced glucocorticoid toxicity","volume":"44","author":"Zhao","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114597_b0760","article-title":"Dexamethasone prodrug nanomedicine (ZSJ-0228) treatment significantly reduces lupus nephritis in mice without measurable side effects - A 5-month study","volume":"102302","author":"Zhao","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114597_b0765","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/IJN.S190027","article-title":"Idarubicin-loaded methoxy poly(ethylene glycol)-b-poly(l-lactide-co-glycolide) nanoparticles for enhancing cellular uptake and promoting antileukemia activity","volume":"14","author":"Liang","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0770","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-13-0230","article-title":"Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity","volume":"7","author":"Majumdar","year":"2014","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114597_b0775","doi-asserted-by":"crossref","DOI":"10.3390\/polym15071808","article-title":"Ligand installation to polymeric micelles for pediatric brain tumor targeting","volume":"15","author":"Watanabe","year":"2023","journal-title":"Polymers (basel)"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0780","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2011.07.027","article-title":"Preparation of polyion complex micelles from poly(ethylene glycol)-block-polyions","volume":"156","author":"Bayo-Puxan","year":"2011","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0785","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020398","article-title":"Dendrimers as modifiers of inorganic nanoparticles for therapeutic delivery in cancer","volume":"15","author":"Zenze","year":"2023","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0790","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejpb.2024.114597_b0795","doi-asserted-by":"crossref","unstructured":"M. Perez-Ferreiro, A MA, A. Criado, I.J. Gomez, J. Mosquera, Dendrimers: exploring their wide structural variety and applications, Polymers (Basel) 15(22) (2023).","DOI":"10.3390\/polym15224369"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0800","doi-asserted-by":"crossref","DOI":"10.3390\/ma13010065","article-title":"Dendrimers as pharmaceutical excipients: synthesis, properties, toxicity and biomedical applications","volume":"13","author":"Santos","year":"2019","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ejpb.2024.114597_b0805","article-title":"Dendrimer-based nanohybrids in cancer photomedicine","volume":"10","author":"Ouyang","year":"2021","journal-title":"Mater. Today Bio"},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024095","article-title":"SPL7013 Gel (VivaGel(R)) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans","volume":"6","author":"Price","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2024.114597_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105089","article-title":"Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro","volume":"191","author":"Paull","year":"2021","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0820","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2005.08.004","article-title":"Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses","volume":"68","author":"Gong","year":"2005","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0825","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jare.2013.07.006","article-title":"Hydrogel: Preparation, characterization, and applications: a review","volume":"6","author":"Ahmed","year":"2015","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0830","doi-asserted-by":"crossref","DOI":"10.3390\/nano12030576","article-title":"Exploring various techniques for the chemical and biological synthesis of polymeric nanoparticles","volume":"12","author":"Pulingam","year":"2022","journal-title":"Nanomaterials (basel)"},{"issue":"9","key":"10.1016\/j.ejpb.2024.114597_b0835","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.201700147","article-title":"Preparation of particulate polymeric therapeutics for medical applications","volume":"1","author":"Zhuang","year":"2017","journal-title":"Small Methods"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0840","doi-asserted-by":"crossref","DOI":"10.3390\/nano6020026","article-title":"Manufacturing techniques and surface engineering of polymer based nanoparticles for targeted drug delivery to cancer","volume":"6","author":"Wang","year":"2016","journal-title":"Nanomaterials (basel)"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0845","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","article-title":"Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists","volume":"20","author":"Joudeh","year":"2022","journal-title":"J Nanobiotechnology."},{"issue":"27","key":"10.1016\/j.ejpb.2024.114597_b0850","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1039\/C8NR02278J","article-title":"Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties","volume":"10","author":"Mourdikoudis","year":"2018","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b0855","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/bc050050z","article-title":"Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments","volume":"16","author":"Sonvico","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2024.114597_b0860","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0865","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future","volume":"47","author":"Muller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0870","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2011.08.033","article-title":"Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines","volume":"420","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0875","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejpb.2011.07.005","article-title":"Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets","volume":"79","author":"Lai","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0880","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2005.05.014","article-title":"Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine","volume":"299","author":"Hecq","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0885","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2009.06.029","article-title":"Effect of wet milling process on the solid state of indomethacin and simvastatin","volume":"380","author":"Sharma","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0890","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2009.03.029","article-title":"Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors","volume":"375","author":"Ali","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0895","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2010.10.007","article-title":"Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling","volume":"149","author":"Ali","year":"2011","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0900","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2010.10.012","article-title":"Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy","volume":"403","author":"Lee","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114597_b0905","doi-asserted-by":"crossref","unstructured":"H. Eerikainen, W. Watanabe, E.I. Kauppinen, P.P. Ahonen, Aerosol flow reactor method for synthesis of drug nanoparticles, Eur. J. Pharm. Biopharm. 55(3) (2003) 357-60.","DOI":"10.1016\/S0939-6411(03)00005-5"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0910","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jps.23024","article-title":"Production and characterization of carbamazepine nanocrystals by electrospraying for continuous pharmaceutical manufacturing","volume":"101","author":"Wang","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114597_b0915","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/btm2.10122","article-title":"Nanocrystals: a perspective on translational research and clinical studies","volume":"4","author":"Jarvis","year":"2019","journal-title":"Bioeng. Transl. Med."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0920","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpharm.2017.10.051","article-title":"Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery \u2013 an update","volume":"535","author":"Jermain","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010051","article-title":"Macrophages recognize size and shape of their targets","volume":"5","author":"Doshi","year":"2010","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0930","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J. Control. Release"},{"issue":"Pt A","key":"10.1016\/j.ejpb.2024.114597_b0935","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2015.09.069","article-title":"Shape and size-dependent immune response to antigen-carrying nanoparticles","volume":"220","author":"Kumar","year":"2015","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.ejpb.2024.114597_b0940","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114597_b0945","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2005.12.003","article-title":"Critical freezing rate in freeze drying nanocrystal dispersions","volume":"111","author":"Lee","year":"2006","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0950","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1248\/bpb1978.5.120","article-title":"Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets","volume":"5","author":"Aoyagi","year":"1982","journal-title":"J. Pharmacobiodyn."},{"issue":"11","key":"10.1016\/j.ejpb.2024.114597_b0955","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1517\/14656566.2.11.1903","article-title":"Sirolimus: a comprehensive review","volume":"2","author":"Kahan","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114597_b0960","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1592\/phco.23.12.1281.32697","article-title":"Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations","volume":"23","author":"Markowitz","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.ejpb.2024.114597_b0965","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2165\/11201140-000000000-00000","article-title":"Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder","volume":"23","author":"Moen","year":"2009","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.ejpb.2024.114597_b0970","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/17425247.2022.2110579","article-title":"Nanocrystals for controlled delivery: state of the art and approved drug products","volume":"19","author":"Kalhapure","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0975","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/07315724.2009.10719778","article-title":"History of parenteral nutrition","volume":"28","author":"Dudrick","year":"2009","journal-title":"J. Am. Coll. Nutr."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b0980","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3746\/pnf.2019.24.3.225","article-title":"Techniques for formulation of nanoemulsion drug delivery system: a review","volume":"24","author":"Kumar","year":"2019","journal-title":"Prev Nutr Food Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b0985","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bja.2018.12.025","article-title":"Propofol infusion syndrome: a structured literature review and analysis of published case reports","volume":"122","author":"Hemphill","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejpb.2024.114597_b0990","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine A delivery to the eye: a comprehensive review of academic and industrial efforts","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b0995","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03256583","article-title":"Clevidipine: a review of its use in the management of acute hypertension","volume":"9","author":"Deeks","year":"2009","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.ejpb.2024.114597_b1000","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/jp.2010.182","article-title":"The use of Omegaven in treating parenteral nutrition-associated liver disease","volume":"31","author":"Park","year":"2011","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ejpb.2024.114597_b1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2021.05.003","article-title":"A four-oil intravenous lipid emulsion improves markers of liver function, triglyceride levels and shortens length of hospital stay in adults: a systematic review and meta-analysis","volume":"92","author":"Xu","year":"2021","journal-title":"Nutr. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b1010","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12040378","article-title":"Stability and safety traits of novel cyclosporine A and tacrolimus ophthalmic galenic formulations involved in vernal keratoconjunctivitis treatment by a high-resolution mass spectrometry approach","volume":"12","author":"Ghiglioni","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2024.114597_b1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2019.108574","article-title":"Combustion and friction-derived nanoparticles and industrial-sourced nanoparticles: the culprit of Alzheimer and Parkinson's diseases","volume":"176","author":"Calderon-Garciduenas","year":"2019","journal-title":"Environ. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b1020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1109\/TNB.2007.909005","article-title":"Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions","volume":"6","author":"Stone","year":"2007","journal-title":"IEEE Trans. NanoBiosci."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114597_b1025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nnano.2017.67","article-title":"The evolving landscape of drug products containing nanomaterials in the United States","volume":"12","author":"D'Mello","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2024.114597_b1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100853","article-title":"The success of nanomedicine","volume":"31","author":"Lammers","year":"2020","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b1035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4155\/tde-2017-0118","article-title":"Nanomedicine: is it lost in translation?","volume":"9","author":"Greish","year":"2018","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b1040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12035-013-8500-0","article-title":"Size- and age-dependent neurotoxicity of engineered metal nanoparticles in rats","volume":"48","author":"Sharma","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b1045","first-page":"79","article-title":"Airborne engineered nanoparticles: potential risks and monitoring challenges for assessing their impacts on children","volume":"13","author":"Biskos","year":"2012","journal-title":"Paediatr. Respir. Rev."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114597_b1050","first-page":"95","article-title":"The developing respiratory tract and its specific needs in regard to ultrafine particulate matter exposure","volume":"13","author":"Schuepp","year":"2012","journal-title":"Paediatr. Respir. Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114597_b1055","first-page":"277","article-title":"Propylene glycol toxicity in children","volume":"19","author":"Lim","year":"2014","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.ejpb.2024.114597_b1060","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJM198211253072206","article-title":"The gasping syndrome and benzyl alcohol poisoning","volume":"307","author":"Gershanik","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114597_b1065","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-3476(82)80586-6","article-title":"Chronic abdominal pain caused by sorbitol malabsorption","volume":"100","author":"Hyams","year":"1982","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114597_b1070","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13030387","article-title":"Excipients in the paediatric population. A review","volume":"13","author":"Rouaz","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114597_b1075","unstructured":"Overview of COVID-19 Vaccines CDC: CDC; [Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/overview-COVID-19-vaccines.html."},{"key":"10.1016\/j.ejpb.2024.114597_b1080","unstructured":"[Available from: https:\/\/www.skyquestt.com\/report\/nanomedicine-market."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124004235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124004235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:43:14Z","timestamp":1738438994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124004235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":216,"alternative-id":["S0939641124004235"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114597","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine for pediatric healthcare: A review of the current state and future prospectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114597"}}